<DOC>
	<DOCNO>NCT00933582</DOCNO>
	<brief_summary>The purpose single-center study evaluate potential analgesic effect single oral dose ( 50 mg ) JNJ-39439335 , investigational drug develop treatment pain patient chronic osteoarthritis pain knee . The study also evaluate pain treatment response assessment method use study . Participants also take naproxen ( 500 mg ) placebo ( inactive substance ) study . Pain assessment take JNJ-39439335 , naproxen placebo compare .</brief_summary>
	<brief_title>A Clinical Study Investigate Effect Pain Relief Single Dose JNJ-39439335 Patients With Chronic Osteoarthritis Pain Knee</brief_title>
	<detailed_description>The purpose single-center study evaluate potential analgesic effect single oral dose JNJ-39439335 ( 50 mg ) , investigational drug develop treatment pain , patient chronic osteoarthritis pain knee . The study also evaluate pain treatment response assessment method use study . Naproxen ( 500 mg ) use active control . The hypothesis study single 50 mg oral dose JNJ-39439335 superior placebo relieve pain patient osteoarthritis knee pain follow exercise . Patients receive JNJ-39439335 , placebo ( inactive substance , like sugar pill ) , naproxen ( 500 mg ) clinic Days 1 , 15 , 29 , base randomly assign ( like flip coin ) treatment sequence . Patients stay clinic pain assessment 4 hour post-dose . At 6 hour post-dose , patient discharge clinic . Patients take naproxen ( 500 mg ) match placebo 12 hour post-dose continue take naproxen ( 500 mg ) match placebo every 12 hour follow 6 day . During study , start first screen visit , patient require discontinue pain medication encourage take rescue medication ( quick-relief fast-acting medication work immediately relieve pain ) , especially dose period , 6 day in-clinic study drug dose Day 1 , Day 15 , Day 29 , respectively . When need , patient may take paracetamol ( 500 mg per dose maximum 2 gram per day ) rescue medication ; however , patient require take rescue medication start 12 hour 6 hour in-clinic dose Day 1 , Day 15 , Day 29 , respectively . Patients ' pain evaluate 3 treatment . Safety assessment , include vital sign , physical exam , electrocardiograms clinical lab test perform timepoints throughout patient ' study participation . Patients receive JNJ-39439335 ( 50 mg ) , placebo , naproxen ( 500 mg ) oral tablet Days 1 , 15 , 29 , base assign treatment sequence . At 12 hour postdose , patient naproxen treatment arm start self-administering naproxen ( 500 mg ) twice daily 6 day patient placebo JNJ-39439335 treatment arm take placebo twice daily 6 day .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Patients chronic osteoarthritis ( OA ) pain knee ( average least 5 day per week 3 month prior screen ) Patients whose OA pain worsens exercise Patients take nonopioid pain medication OA knee pain daily benefit least 5 day week prior screen Women must postmenopausal unable child Otherwise healthy Patients orthopedic and/or prosthetic device knee significant pain related knee , include significant hip back pain judgement investigator interfere pain measure knee ( Patients OA knee allow study ) Unable discontinue formulation prior pain medication paracetamol study Unable discontinue paracetamol 12 hour prior clinic visit Patients history active peptic ulceration , active dyspepsia , gastrointestinal bleeding , Crohn 's disease , ulcerative colitis , chronic diarrhea esophageal , gastric duodenal ulcer within 3 month prior screen Patients surgery chronic pain within 3 month prior Screening plan surgery study Patients history prior diagnosis inflammatory arthritis include rheumatoid arthritis</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Osteoarthritis , Knee</keyword>
	<keyword>Knee Pain</keyword>
	<keyword>Pain Measurement</keyword>
	<keyword>Naproxen</keyword>
	<keyword>Placebo</keyword>
	<keyword>Treatment Outcome</keyword>
</DOC>